FDA Issues Final Guidance on Rx Drug Apps
The FDA released final guidance establishing a framework for developing, distributing, and labeling prescription drug apps. The final rule clarifies regulatory oversight by classifying certain apps under existing medical device authorities.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed